Stockreport

2seventy bio Reports First Quarter Financial Results and Recent Operational Progress [Yahoo! Finance]

2seventy bio, Inc.  (TSVT) 
PDF Completion of R&D Pipeline Divestiture to Regeneron Sets Company on Track to Focus Exclusively on Development and Commercialization of Abecma with Streamlined Cost Stru [Read more]